Effect of suberoylanilide hydroxamic acid (SAHA) Administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-Infected Indian rhesus macaques

Gregory Q. Del Prete, Rebecca Shoemaker, Kelli Oswald, Abigail Lara, Charles M. Trubey, Randy Fast, Douglas K. Schneider, Rebecca Kiser, Vicky Coalter, Adam Wiles, Rodney Wiles, Brandi Freemire, Brandon F. Keele, Jacob Estes, Octavio A. Quiñones, Jeremy Smedley, Rhonda MacAllister, Rosa I. Sanchez, John S. Wai, Christopher M. TanW. Gregory Alvord, Daria J. Hazuda, Michael Piatak, Jeffrey D. Lifson

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Nonhuman primate models are needed for evaluations of proposed strategies targeting residual virus that persists in HIV-1- infected individuals receiving suppressive combination antiretroviral therapy (cART). However, relevant nonhuman primate (NHP) models of cART-mediated suppression have proven challenging to develop. We used a novel three-class, six-drug cART regimen to achieve durable 4.0- to 5.5-log reductions in plasma viremia levels and declines in cell-associated viral RNA and DNA in blood and tissues of simian immunodeficiency virus SIVmac239-infected Indian-origin rhesus macaques, then evaluated the impact of treatment with the histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA; Vorinostat) on the residual virus pool. Ex vivo SAHA treatment of CD4 T cells obtained from cART-suppressed animals increased histone acetylation and viral RNA levels in culture supernatants. cART-suppressed animals each received 84 total doses of oral SAHA. We observed SAHA dose-dependent increases in acetylated histones with evidence for sustained modulation as well as refractoriness following prolonged administration. In vivo virologic activity was demonstrated based on the ratio of viral RNA to viral DNA in peripheral blood mononuclear cells, a presumptive measure of viral transcription, which significantly increased in SAHAtreated animals. However, residual virus was readily detected at the end of treatment, suggesting that SAHA alone may be insufficient for viral eradication in the setting of suppressive cART. The effects observed were similar to emerging data for repeat-dose SAHA treatment of HIV-infected individuals on cART, demonstrating the feasibility, utility, and relevance of NHP models of cART-mediated suppression for in vivo assessments of AIDS virus functional cure/eradication approaches.

Original languageEnglish (US)
Pages (from-to)6790-6806
Number of pages17
JournalAntimicrobial Agents and Chemotherapy
Volume58
Issue number11
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Macaca mulatta
Viruses
Viral RNA
Therapeutics
Primates
Viral DNA
Histones
vorinostat
HIV
Simian Immunodeficiency Virus
Histone Deacetylase Inhibitors
Viremia
Acetylation
Combination Drug Therapy
HIV-1
Blood Cells
T-Lymphocytes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Effect of suberoylanilide hydroxamic acid (SAHA) Administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-Infected Indian rhesus macaques. / Del Prete, Gregory Q.; Shoemaker, Rebecca; Oswald, Kelli; Lara, Abigail; Trubey, Charles M.; Fast, Randy; Schneider, Douglas K.; Kiser, Rebecca; Coalter, Vicky; Wiles, Adam; Wiles, Rodney; Freemire, Brandi; Keele, Brandon F.; Estes, Jacob; Quiñones, Octavio A.; Smedley, Jeremy; MacAllister, Rhonda; Sanchez, Rosa I.; Wai, John S.; Tan, Christopher M.; Alvord, W. Gregory; Hazuda, Daria J.; Piatak, Michael; Lifson, Jeffrey D.

In: Antimicrobial Agents and Chemotherapy, Vol. 58, No. 11, 01.11.2014, p. 6790-6806.

Research output: Contribution to journalArticle

Del Prete, GQ, Shoemaker, R, Oswald, K, Lara, A, Trubey, CM, Fast, R, Schneider, DK, Kiser, R, Coalter, V, Wiles, A, Wiles, R, Freemire, B, Keele, BF, Estes, J, Quiñones, OA, Smedley, J, MacAllister, R, Sanchez, RI, Wai, JS, Tan, CM, Alvord, WG, Hazuda, DJ, Piatak, M & Lifson, JD 2014, 'Effect of suberoylanilide hydroxamic acid (SAHA) Administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-Infected Indian rhesus macaques', Antimicrobial Agents and Chemotherapy, vol. 58, no. 11, pp. 6790-6806. https://doi.org/10.1128/AAC.03746-14
Del Prete, Gregory Q. ; Shoemaker, Rebecca ; Oswald, Kelli ; Lara, Abigail ; Trubey, Charles M. ; Fast, Randy ; Schneider, Douglas K. ; Kiser, Rebecca ; Coalter, Vicky ; Wiles, Adam ; Wiles, Rodney ; Freemire, Brandi ; Keele, Brandon F. ; Estes, Jacob ; Quiñones, Octavio A. ; Smedley, Jeremy ; MacAllister, Rhonda ; Sanchez, Rosa I. ; Wai, John S. ; Tan, Christopher M. ; Alvord, W. Gregory ; Hazuda, Daria J. ; Piatak, Michael ; Lifson, Jeffrey D. / Effect of suberoylanilide hydroxamic acid (SAHA) Administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-Infected Indian rhesus macaques. In: Antimicrobial Agents and Chemotherapy. 2014 ; Vol. 58, No. 11. pp. 6790-6806.
@article{b95ed3624aa94f6fba4d2edc89021eff,
title = "Effect of suberoylanilide hydroxamic acid (SAHA) Administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-Infected Indian rhesus macaques",
abstract = "Nonhuman primate models are needed for evaluations of proposed strategies targeting residual virus that persists in HIV-1- infected individuals receiving suppressive combination antiretroviral therapy (cART). However, relevant nonhuman primate (NHP) models of cART-mediated suppression have proven challenging to develop. We used a novel three-class, six-drug cART regimen to achieve durable 4.0- to 5.5-log reductions in plasma viremia levels and declines in cell-associated viral RNA and DNA in blood and tissues of simian immunodeficiency virus SIVmac239-infected Indian-origin rhesus macaques, then evaluated the impact of treatment with the histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA; Vorinostat) on the residual virus pool. Ex vivo SAHA treatment of CD4 T cells obtained from cART-suppressed animals increased histone acetylation and viral RNA levels in culture supernatants. cART-suppressed animals each received 84 total doses of oral SAHA. We observed SAHA dose-dependent increases in acetylated histones with evidence for sustained modulation as well as refractoriness following prolonged administration. In vivo virologic activity was demonstrated based on the ratio of viral RNA to viral DNA in peripheral blood mononuclear cells, a presumptive measure of viral transcription, which significantly increased in SAHAtreated animals. However, residual virus was readily detected at the end of treatment, suggesting that SAHA alone may be insufficient for viral eradication in the setting of suppressive cART. The effects observed were similar to emerging data for repeat-dose SAHA treatment of HIV-infected individuals on cART, demonstrating the feasibility, utility, and relevance of NHP models of cART-mediated suppression for in vivo assessments of AIDS virus functional cure/eradication approaches.",
author = "{Del Prete}, {Gregory Q.} and Rebecca Shoemaker and Kelli Oswald and Abigail Lara and Trubey, {Charles M.} and Randy Fast and Schneider, {Douglas K.} and Rebecca Kiser and Vicky Coalter and Adam Wiles and Rodney Wiles and Brandi Freemire and Keele, {Brandon F.} and Jacob Estes and Qui{\~n}ones, {Octavio A.} and Jeremy Smedley and Rhonda MacAllister and Sanchez, {Rosa I.} and Wai, {John S.} and Tan, {Christopher M.} and Alvord, {W. Gregory} and Hazuda, {Daria J.} and Michael Piatak and Lifson, {Jeffrey D.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1128/AAC.03746-14",
language = "English (US)",
volume = "58",
pages = "6790--6806",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Effect of suberoylanilide hydroxamic acid (SAHA) Administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-Infected Indian rhesus macaques

AU - Del Prete, Gregory Q.

AU - Shoemaker, Rebecca

AU - Oswald, Kelli

AU - Lara, Abigail

AU - Trubey, Charles M.

AU - Fast, Randy

AU - Schneider, Douglas K.

AU - Kiser, Rebecca

AU - Coalter, Vicky

AU - Wiles, Adam

AU - Wiles, Rodney

AU - Freemire, Brandi

AU - Keele, Brandon F.

AU - Estes, Jacob

AU - Quiñones, Octavio A.

AU - Smedley, Jeremy

AU - MacAllister, Rhonda

AU - Sanchez, Rosa I.

AU - Wai, John S.

AU - Tan, Christopher M.

AU - Alvord, W. Gregory

AU - Hazuda, Daria J.

AU - Piatak, Michael

AU - Lifson, Jeffrey D.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Nonhuman primate models are needed for evaluations of proposed strategies targeting residual virus that persists in HIV-1- infected individuals receiving suppressive combination antiretroviral therapy (cART). However, relevant nonhuman primate (NHP) models of cART-mediated suppression have proven challenging to develop. We used a novel three-class, six-drug cART regimen to achieve durable 4.0- to 5.5-log reductions in plasma viremia levels and declines in cell-associated viral RNA and DNA in blood and tissues of simian immunodeficiency virus SIVmac239-infected Indian-origin rhesus macaques, then evaluated the impact of treatment with the histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA; Vorinostat) on the residual virus pool. Ex vivo SAHA treatment of CD4 T cells obtained from cART-suppressed animals increased histone acetylation and viral RNA levels in culture supernatants. cART-suppressed animals each received 84 total doses of oral SAHA. We observed SAHA dose-dependent increases in acetylated histones with evidence for sustained modulation as well as refractoriness following prolonged administration. In vivo virologic activity was demonstrated based on the ratio of viral RNA to viral DNA in peripheral blood mononuclear cells, a presumptive measure of viral transcription, which significantly increased in SAHAtreated animals. However, residual virus was readily detected at the end of treatment, suggesting that SAHA alone may be insufficient for viral eradication in the setting of suppressive cART. The effects observed were similar to emerging data for repeat-dose SAHA treatment of HIV-infected individuals on cART, demonstrating the feasibility, utility, and relevance of NHP models of cART-mediated suppression for in vivo assessments of AIDS virus functional cure/eradication approaches.

AB - Nonhuman primate models are needed for evaluations of proposed strategies targeting residual virus that persists in HIV-1- infected individuals receiving suppressive combination antiretroviral therapy (cART). However, relevant nonhuman primate (NHP) models of cART-mediated suppression have proven challenging to develop. We used a novel three-class, six-drug cART regimen to achieve durable 4.0- to 5.5-log reductions in plasma viremia levels and declines in cell-associated viral RNA and DNA in blood and tissues of simian immunodeficiency virus SIVmac239-infected Indian-origin rhesus macaques, then evaluated the impact of treatment with the histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA; Vorinostat) on the residual virus pool. Ex vivo SAHA treatment of CD4 T cells obtained from cART-suppressed animals increased histone acetylation and viral RNA levels in culture supernatants. cART-suppressed animals each received 84 total doses of oral SAHA. We observed SAHA dose-dependent increases in acetylated histones with evidence for sustained modulation as well as refractoriness following prolonged administration. In vivo virologic activity was demonstrated based on the ratio of viral RNA to viral DNA in peripheral blood mononuclear cells, a presumptive measure of viral transcription, which significantly increased in SAHAtreated animals. However, residual virus was readily detected at the end of treatment, suggesting that SAHA alone may be insufficient for viral eradication in the setting of suppressive cART. The effects observed were similar to emerging data for repeat-dose SAHA treatment of HIV-infected individuals on cART, demonstrating the feasibility, utility, and relevance of NHP models of cART-mediated suppression for in vivo assessments of AIDS virus functional cure/eradication approaches.

UR - http://www.scopus.com/inward/record.url?scp=84908577564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908577564&partnerID=8YFLogxK

U2 - 10.1128/AAC.03746-14

DO - 10.1128/AAC.03746-14

M3 - Article

C2 - 25182644

AN - SCOPUS:84908577564

VL - 58

SP - 6790

EP - 6806

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 11

ER -